New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

Adults with plaque psoriasis aged 65 years and older had similar responses to IL-17 and IL-23 inhibitors to that of younger adults.

Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders, according ...

Discover a study in which researchers examined three international cohorts of patients with moderate-to-severe psoriasis ...

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by high-sensitivity C-reactive protein, despite ...

Epidermolysis bullosa is a rare and severe skin disease where patients have fragile skin that blisters and tears. A Mt.

Jasmine Espy, a Hidradenitis Suppurativa warrior experienced her first burning and confusing abscess under her arm at the age ...

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

A 50-year-old woman, A, recently woke up in the morning and felt a sharp pain in her heels every time she took her first step ...

There is no cure. “Only the sun, that living god, had real power over psoriasis,” wrote the great American novelist John Updike in his essay “At War with My Skin”, published in The New Yorker in 1985.

I think within my lifetime we may see curing of psoriasis," said Andrew Blauvelt, MD, of Blauvelt Consultants in Annapolis, Maryland, during a session at the recent American Academy of Dermatology ...